About Elut Inc
Elut Inc is a company based in Salt Lake City (United States) founded in 2011.. Elut Inc has raised $1.64 million across 1 funding round. The company has 5 employees as of December 31, 2024. Elut Inc offers products and services including BONVIE+ EP GRANULES WITH TOBRAMYCIN. Elut Inc operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Salt Lake City, United States
- Employees 5 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Elute, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.64 M (USD)
in 1 rounds
-
Latest Funding Round
$1.64 M (USD), Series A
Mar 31, 2016
-
Investors
-
Employee Count
5
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elut Inc
Elut Inc offers a comprehensive portfolio of products and services, including BONVIE+ EP GRANULES WITH TOBRAMYCIN. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers sustained antibiotic release for treating bone infections effectively.
Unlock access to complete
Unlock access to complete
Funding Insights of Elut Inc
Elut Inc has successfully raised a total of $1.64M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.64 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $1.6M
-
First Round
First Round
(31 Mar 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2016 | Amount | Series A - Elut Inc | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Elut Inc
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Elut Inc
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Elut Inc Comparisons
Competitors of Elut Inc
Elut Inc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Elut Inc
Frequently Asked Questions about Elut Inc
When was Elut Inc founded?
Elut Inc was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Where is Elut Inc located?
Elut Inc is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Is Elut Inc a funded company?
Elut Inc is a funded company, having raised a total of $1.64M across 1 funding round to date. The company's 1st funding round was a Series A of $1.64M, raised on Mar 31, 2016.
How many employees does Elut Inc have?
As of Dec 31, 2024, the latest employee count at Elut Inc is 5.
What does Elut Inc do?
Elute is focussed on developing polymeric controlled drug delivery devices to prevent and treat orthopedic and other surgical bone infections. Using the technology which employs the patented and patent-pending polymer ceramic composites, it is developing products which provide a clinically relevant delivery of antibiotics and other therapeutic agents directly into surgical sites of patients undergoing orthopedic and other procedures. Its first product candidate, ElutiBone claims to have demonstrated the controlled release of certain antibiotics in a therapeutic range for a 6-8 week period. It also claims to minimize the side effects of developing antibiotic resistance associated with antibiotic-loaded bone cements.
Who are the top competitors of Elut Inc?
Elut Inc's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Elut Inc offer?
Elut Inc offers BONVIE+ EP GRANULES WITH TOBRAMYCIN.